IE43950L - 6-amidinopenicillanic acid derivatives - Google Patents
6-amidinopenicillanic acid derivativesInfo
- Publication number
- IE43950L IE43950L IE762191A IE219176A IE43950L IE 43950 L IE43950 L IE 43950L IE 762191 A IE762191 A IE 762191A IE 219176 A IE219176 A IE 219176A IE 43950 L IE43950 L IE 43950L
- Authority
- IE
- Ireland
- Prior art keywords
- hydrochloride
- treating
- diastereomeric
- ethoxycarbonyloxyethyl
- base
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1529448 1<SP>1</SP>-Ethoxycarbonyloxy-ethyl 6-(hexahydro-1H-azepin-1-yl-methyleneamino)-penicillanate LEO PHARMACEUTICAL PRODUCTS Ltd AS 8 Oct 1976 [29 Oct 1975] 44676/75 Heading C2C [Also in Division A5] Novel crystalline diastereomeric forms of 1<SP>1</SP> - ethoxycarbonyloxyethyl - 6 - (hexahydro- 1H - azepin - 1 - yl - methyleneamino) - penicillenate or its hydrochloride are prepared (a) by adding an equivalent of HCl in propanol- 2 to an ethereal solution of mixture of the free base forms, treating the isolated crystals with acetone and recrystallizing them from methanolether to give one diastereomeric hydrochloride, and evaporating the mother liquor and treating the residue with methanol-ether or propanol-2- diisopropyl ether to crystallize the other diastereomeric hydrochloride; or (b) by dissolving the free base in ether, adding cold water, adjusting to pH3À0 with NHCl, freeze-drying the aqueous phase, treating the amorphous mixture with acetone to crystallize one diastereomeric hydrochloride, evaporating the mother liquor, treating the residue with aqueous NaHCO 3 , purifying the liberated base with an ionexchange resin, converting it to the hydrochloride and crystallizing it from ethyl acetate to give the other diastereomeric hydrochloride; or (c) by neutralizing an aqueous solution of the diastereomeric hydrochloride with a base, such as NaHCO 3 to crystallize the diastereomeric base. 1<SP>1</SP>-Ethoxycarbonyloxyethyl 6-(hexahydro-1H- azepin-1-yl-methyleneamino)-penicillinate is prepared as an amorphous mixture of diastereomers by reacting potassium benzylpenicillanate with 1-chloroethylethyl carbonate, treating the resulting 1<SP>1</SP>-ethoxycarbonyloxyethyl benzylpenicillanate with phosphorus pentachloride and quinoline in chloroform, and treating the resulting 1<SP>1</SP>-ethoxycarbonyloxyethyl 6-amino-penicillanate with the dimethyl sulphate complex of N-formyl-hexamethyleneimine.
[GB1529448A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB44676/75A GB1529448A (en) | 1975-10-29 | 1975-10-29 | 6-amidinopenicillanic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IE43950L true IE43950L (en) | 1977-04-29 |
IE43950B1 IE43950B1 (en) | 1981-07-01 |
Family
ID=10434309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2191/76A IE43950B1 (en) | 1975-10-29 | 1976-10-05 | New 6-amidinopenicillanic acid derivatives |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5257190A (en) |
AU (1) | AU501771B2 (en) |
BE (1) | BE847749A (en) |
DE (1) | DE2649183A1 (en) |
FR (1) | FR2329287A1 (en) |
GB (1) | GB1529448A (en) |
IE (1) | IE43950B1 (en) |
NZ (1) | NZ182323A (en) |
ZA (1) | ZA766165B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1427139A (en) * | 1972-03-13 | 1976-03-10 | Astra Laekemedel Ab | Penicillins |
-
1975
- 1975-10-29 GB GB44676/75A patent/GB1529448A/en not_active Expired
-
1976
- 1976-10-05 IE IE2191/76A patent/IE43950B1/en unknown
- 1976-10-13 NZ NZ182323A patent/NZ182323A/en unknown
- 1976-10-14 AU AU18673/76A patent/AU501771B2/en not_active Expired
- 1976-10-15 ZA ZA766165A patent/ZA766165B/en unknown
- 1976-10-27 FR FR7632412A patent/FR2329287A1/en active Granted
- 1976-10-27 JP JP51128415A patent/JPS5257190A/en active Pending
- 1976-10-28 DE DE19762649183 patent/DE2649183A1/en not_active Ceased
- 1976-10-28 BE BE171883A patent/BE847749A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5257190A (en) | 1977-05-11 |
GB1529448A (en) | 1978-10-18 |
AU501771B2 (en) | 1979-06-28 |
BE847749A (en) | 1977-04-28 |
ZA766165B (en) | 1977-09-28 |
FR2329287A1 (en) | 1977-05-27 |
AU1867376A (en) | 1978-04-20 |
IE43950B1 (en) | 1981-07-01 |
DE2649183A1 (en) | 1977-05-12 |
NZ182323A (en) | 1984-07-31 |
FR2329287B1 (en) | 1979-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE802658L (en) | Crystalline sweetener | |
US3240775A (en) | Preparation of alpha-l-fucosides and l-fucose from fucoidan | |
COXON et al. | Simplified preparation of sophorose (2-O-β-d-glucopyranosyl-d-glucose) | |
IE830817L (en) | Process for preparing l-ascorbic acid | |
US2969353A (en) | Process for the preparation of "active methionine" and products obtained thereby | |
IE43950L (en) | 6-amidinopenicillanic acid derivatives | |
US3539550A (en) | Process for the preparation of 2'-halo-2'-deoxy pyrimidine nucleosides | |
US2993833A (en) | Erythromycin esters | |
US4737584A (en) | Process for cyclo-dehydrating ketoses | |
US4910222A (en) | Cysteine derivatives having expectorant activity | |
Ness et al. | The Reduction of Various Sugar Acids to Glycitols with Lithium Aluminum Hydride | |
GB1452452A (en) | Manufacture of optically active-p-hydroxyphenylglycine and salts thereof | |
Frush et al. | Amides of glucuronic, galacturonic, and mannuronic acids | |
JPS55167267A (en) | Purification of alpha-l-aspartyl-l-phenylalanine lower alkyl ester | |
US3322771A (en) | Intermediates for preparing thebaine derivatives | |
US4051149A (en) | 6,11-Dihydrodibenzo-[b.e.]-thiepin-11-one-3-acetonitrile | |
Wolfrom et al. | Thioglycosides of 3-Amino-3-deoxy-D-mannose1 | |
US2832719A (en) | Nystatin purification | |
US2380444A (en) | Chemical process and products | |
US2013536A (en) | Acetyl choline acetate | |
KR970042564A (en) | High-density, highly crystalline Ceperazone sodium salt and preparation method thereof | |
IL26522A (en) | Preparation of 4'-demethyl-epipodophyllotoxin | |
US2232712A (en) | Fully acetylated sugar acids and processes for their production | |
IL33548A (en) | Galactopyranosides as lincomycin intermediates | |
US3284489A (en) | Calcium mono-glycine acetylsalicylate |